+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients



Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients



Biological Psychiatry 56(6): 418-426



Vagus nerve stimulation (VNS) has shown promising antidepressant effects in treatment-resistant depression, but the mechanisms of action are not known. Cerebrospinal fluid (CSF) studies in epilepsy patients show that VNS alters concentrations of monamines and gamma-aminobutyric acid (GABA), neurotransmitter systems possibly involved in the pathogenesis of depression. Twenty-one adults with treatment-resistant, recurrent, or chronic major depression underwent standardized lumbar puncture for collection of 12 mL CSF on three separate but identical procedure days during participation in the VNS D-02 clinical trial. All subjects remained on stable regimens of mood medications. Collections were made at baseline (2 weeks after surgical implantation but before device activation), week 12 (end of the acute-phase study), and week 24. Cerebrospinal fluid concentrations of norepinephrine (NE), 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA), and 3-methoxy-4-hydroxyphenylglycol (MHPG) were determined with high-performance liquid chromatography. Concentrations of GABA were assayed with mass spectrometry. Comparison of sham versus active VNS revealed a significant (mean 21%) VNS-associated increase in CSF HVA. Mean CSF concentrations of NE, 5-HIAA, MHPG, and GABA did not change significantly. Higher baseline HVA/5-HIAA ratio predicted worse clinical outcome. Although several of the CSF neurochemical effects we observed in this VNS study were similar to those described in the literature for antidepressants and electroconvulsive therapy, the results do not suggest a putative antidepressant mechanism of action for VNS.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012006031

Download citation: RISBibTeXText

PMID: 15364040

DOI: 10.1016/j.biopsych.2004.06.025


Related references

Cerebrospinal fluid levels of monoamine metabolites and gamma-aminobutyric acid in neuroleptic malignant syndrome. Journal Of Psychiatric Research. 29(3): 233-244, 1995

Cerebrospinal fluid values for monoamine metabolites, gamma-aminobutyric acid, and other amino compounds in Rett syndrome. Journal of Pediatrics 112(2): 234-238, 1988

Changes in cerebrospinal fluid monoamine metabolites, tryptophan, and gamma-aminobutyric acid during the 1st year of life in normal infants. comparison with victims of sudden infant death syndrome. Biology of the Neonate 75(3): 152-159, 1999

Tardive dyskinesia and neurotransmitters: effects of sodium valproate, cyproheptadine, oxypertine, hydroxyzine pamoate and Ca-hopantenate on monoamine metabolites, cyclic nucleotides and gamma-aminobutyric acid in human cerebrospinal fluid. Clinical Therapeutics 7 Spec No: 1-17, 1984

Tardive dyskinesia and neurotransmitters effects of sodium valproate cyproheptadine oxypertine hydroxyzine pamoate and calcium hopantenate on monoamine metabolites cyclic nucleotides and gamma aminobutyric acid in human cerebrospinal fluid. Clinical Therapeutics 7(SPEC ISSUE): 1-17, 1984

The effect of paroxetine on cerebrospinal fluid concentrations of neurotransmitter metabolites in depressed patients. European Neuropsychopharmacology 4(1): 1-6, 1994

Changes in Cerebrospinal Fluid Monoamine Metabolites, Tryptophan, and -Aminobutyric Acid during the 1st Year of Life in Normal Infants. Neonatology 75(3): 152-159, 1999

Monoamine metabolites in cerebrospinal fluid of depressed patients during treatment with mianserin or amitriptyline. Journal of Affective Disorders 4(3): 219-226, 1982

Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study. Archives of General Psychiatry 46(7): 609-612, 1989

Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls. Psychiatry Research 4(1): 21-29, 1981

Gamma-Aminobutyric acid concentrations in the cerebrospinal fluid of newborn infants. Early Human Development 7(1): 53-58, 1982

Pharmacokinetics of vigabatrin gamma vinyl gamma aminobutyric acid and gamma aminobutyric acid as revealed by repeated plasma and cerebrospinal fluid sampling. Neurology 36(4 Suppl. 1): 325, 1986

Effect of age on cisternal cerebrospinal fluid concentrations of monoamine metabolites in nonhuman primates. Neurochemistry International 13(3): 353-358, 1988

Effect of ischemia on monoamine metabolism. Brain monoamine metabolites in cerebrospinal fluid of patients with recent cerebral infarction. NeuropatologiaPolska20(1-2):97, 1982

Neuronal gamma aminobutyric acid hypofunction in tardive dyskinesia cerebrospinal fluid gamma aminobutyric acid levels and saccadic eye movements. Society for Neuroscience Abstracts 12(1): 479, 1986